Rare diseases
Investigational molecules
Locations
A study to evaluate the safety and effectiveness of HLX43 in patients with advanced non-small cell lung cancer
PolandA study to evaluate the effectiveness of barzolvolimab in participants with cold urticaria and symptomatic dermographism
PolandA study to evaluate the effectiveness and safety of LAD603 in adults with severe to very severe alopecia areata
PolandA study to evaluate the effectiveness and safety of lebrikizumab in adults with nummular eczema who do not respond well to topical corticosteroids.
PolandA Phase III Study of Survodutide in Adults with Compensated NASH Cirrhosis to Assess Liver Outcomes and Safety
PolandA Phase III trial of BI 456906 weekly injections in adults with NASH and stage 2‑3 liver fibrosis
PolandA study to evaluate the effects of BI 764198 in adults and adolescents with focal segmental glomerulosclerosis (FSGS)
PolandA study to evaluate the long-term safety and effectiveness of barzolvolimab in patients with chronic spontaneous urticaria
PolandA study to evaluate the effectiveness and safety of usnoflast in adults with Amyotrophic Lateral Sclerosis (ALS)
PolandStudy of sotorasib, panitumumab and a drug combination for patients with metastatic colorectal cancer with KRAS p.G12C mutation.
PolandStudy to evaluate the long-term safety and effectiveness of lunsekimig in adults with moderate to severe asthma
PolandStudy of BNT327 and a drug combination for patients with untreated metastatic or locally recurrent triple-negative breast cancer
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
